21579 ā
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
MINIPROTEINS, CONJUGATES & USES THEREOF
#2LEUKOCYTE-SPECIFIC CELL PENETRATING MOLECULES
#3SOMATOSTATIN RECEPTOR-TARGETING RADIOPHARMACEUTICALS AND USES THEREOF
#4Mesothelin-Binding Theranostic Fibronectin Type III Tenth Domain (Fn3) Compounds
#5PEPTIDE STRUCTURE TARGETING CARBONIC DEHYDROGENASE IX AND USE THEREOF
#6TRIFUNCTIONAL COMPOUND AND USE THEREOF
#7HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#8COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS
#9RADIOPHARMACEUTICALS TARGETING CARBONIC ANHYDRASE IX PROTEINS
#10CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY
#11CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY
#12Fibroblast Activation Protein Alpha-Cleavable Pro-Peptides and Methods of Use
#13PREVENTION AND/OR TREATMENT OF CARDIAC DAMAGE
#14PHYTIC ACID-BASED TERNARY COMPLEX BIOMIMETIC NANOMATERIAL, AND PREPARATION METHOD AND USE THEREOF
#15177LUTETIUM-DOTA-TATE FORMULATIONS
#16Radiolabelled Compounds
#17A FORMULATION OF A CONJUGATE OF A TUBULYSIN ANALOG TO A CELL-BINDING MOLECULE
#18PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF
#19RADIOPHARMACEUTICAL COMPOSITIONS FOR ACTINIUM IN TARGETED RADIONUCLIDE THERAPY
#20RADIOPHARMACEUTICAL COMPOSITIONS FOR ACTINIUM IN TARGETED RADIONUCLIDE THERAPY
#21GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-TARGETED COMPOUNDS AND USES THEREOF
#22METHODS AND COMPOSITIONS FOR IMAGING MALIGNANCIES IN THE BONE MARROW
#23Targeted Delivery of Theranostic Agents
#24MULTI-TARGETING COMPOUND AND USE THEREOF
#25FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING AND USE THEREOF IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES
#26ZWITTERIONIC COMPOUNDS AND USES THEREOF
#27LIGAND COMPOUND TARGETING PSMA ANTIGEN, AND CHELATE AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#28COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF
#29CYCLIC PEPTIDE AND PREPARATION METHOD THEREFOR, AND COMPLEX COMPRISING SAME AND USE THEREOF
#30Radiopharmaceuticals at Different Activity Reference Times
#31HETERODIMER AND RADIOACTIVE MEDICAL USE THEREOF
#32DIMERIC RADIOPHARMACEUTICALS, COMPOSITIONS THEREOF AND USES THEREOF
#33METHODS FOR LARGE SCALE SYNTHESIS OF RADIONUCLIDE COMPLEXES
#34HALOGENATED SOMATOSTATIN ANALOGS WITH MULTIPLE SOMATOSTATIN RECEPTOR SUBTYPE SELECTIVITY
#35B7-H3 MINIPROTEINS, CONJUGATES, AND USES THEREOF
#36PET TRACER FOR DETECTION OF TRANSFORMING GROWTH FACTOR BETA
#37NECTIN-4 MINIPROTEIN CONJUGATES
#38SILICON-BASED FLUORIDE ACCEPTOR GROUPS FOR RADIOPHARMACEUTICALS
#39POLYPEPTIDE COMPOUND, AND COMPLEX AND USE THEREOF
#40RADIOPHARMACEUTICAL SMALL MOLECULE INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN FOR TARGETED THERAPY AND DIAGNOSTIC IMAGING OF DESMOPLASTIC TUMORS
#41COMBINATION THERAPY OF RADIONUCLIDE COMPLEX
#42NANOPLATFORM FOR TARGETING INFLAMMATORY MACROPHAGES, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY DISEASES
#43OLIGONUCLEOTIDE-BASED THERAPEUTICS AND USES THEREOF
#44METHODS AND KITS FOR PREPARING RADIONUCLIDE COMPLEXES
#45RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY
#46COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS
#47COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER
#48CARBONIC ANHYDRASE IX LIGANDS
#49PRECURSOR AND RADIOTRACER FOR NEUROENDOCRINE THERANOSTICS
#50COMPOUNDS WITH IMPROVED PHARMACOKINETICS FOR IMAGING AND THERAPY OF CANCER
#51STABLE, CONCENTRATED RADIOPHARMACEUTICAL COMPOSITION
#52HER2 TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF
#53COMPOUND TARGETING SSTR2, PREPARATION METHOD THEREFOR AND USE THEREOF
#54TRANSFERRIN RECEPTOR TARGETING PEPTIDE OLIGONUCLEOTIDE COMPLEXES AND METHODS OF USE THEREOF
#55TARGETING LIGANDS FOR DISEASE-TARGETED IMAGING AGENTS AND METHODS OF USE THEREFOR
#56UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS (HNSCCS)
#57A NOVEL KIT FOR RADIOPHARMACEUTICAL PREPARATION OF A RADIOMETAL LABELED CHELATE-FUNCTIONALIZED TARGETING CONJUGATE
#58KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF
#59GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS
#60B7-H3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF
#61TARGETED RADIOPHARMACEUTICAL FOR TUMOR AND ITS USE IN THE IMAGING-GUIDED COMBINATION THERAPY OF TARGETED RADIOTHERAPY AND IMMUNOTHERAPY
#62CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF
#63NANOPLATFORM FOR TARGETING INFLAMMATORY MACROPHAGES, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY DISEASES
#64Improving the Efficiency of PAL-Catalyzed Protein Ligation By A Cascade Enzymatic Scheme
#65PEPTIDE LIGAND TARGETING CARBONIC ANHYDRASE IX, PEPTIDE CONSTRUCT COMPRISING SAME, AND USES THEREOF
#66STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#67MINIPROTEINS, CONJUGATES & USES THEREOF
#68CXCR4-TARGETING COMPOUNDS, AND METHODS OF MAKING AND USING THE SAME
#69TRISLINKER-CONJUGATED DIMERIC LABELING PRECURSORS AND RADIOTRACERS DERIVED THEREFROM
#70Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof
#71FUSION PROTEIN COMPRISING AN EGFR-BINDING DOMAIN AND A MASKING DOMAIN
#72METHOD FOR PROVIDING A LABELED SINGLE ISOMERIC CHEMICAL ENTITY TARGETING VECTOR BASED ON THE USE OF AN ISOMER-FREE DIENOPHILE
#73ENRICHED AND STABLE RADIOLIGAND THERAPY FORMULATIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
#74RADIOPHARMACEUTICAL COMPOSITIONS, SYNTHETIC METHODS, AND METHODS OF TREATMENT
#75RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS
#76METHODS OF TREATING SMALL CELL LUNG CANCER
#77METHODS FOR IMAGING INTEGRIN EXPRESSION AND FOR IMAGING SITES OF ENDOMETRIOSIS
#78HIGH-AFFINITY LIGANDS OF FIBROBLAST ACTIVATION PROTEIN FOR TARGETED DELIVERY APPLICATIONS
#79STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES
#80CD206 Targeted Peptide Conjugates and Methods of Using the Same
#81RGD DIMER COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
#82Albumin Conjugates and Process for Preparation thereof
#83ALBUMIN CONJUGATES AND RADIOPHARMACEUTICAL COMPOSITION THEREOF
#84Fibroblast activation protein compound or salt with albumin dual-binding function
#85IMPROVED ALUMINUM FLUORIDE RADIOSYNTHESIS OF [18F]DK222
#86CHOLECYSTOKININ B RECEPTOR-TARGETED COMPLEX AND A CONTRAST AGENT THEREOF
#87DETECTION AND LOCALIZATION OF INTERNAL BLEEDING
#88[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
#89PEPTIDE UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE UREA DERIVATIVE, AND APPLICATION OF PEPTIDE UREA DERIVATIVE
#90METHODS AND KITS FOR PREPARING RADIONUCLIDE COMPLEXES
#91PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#92CLEAVABLE RADIOLIGANDS FOR TARGETING CELL SURFACE RECEPTORS AND USES THEREOF
#93FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF
#94IMMUNOSTIMULANT-CYTOTOXIC CONJUGATE COMPOSITION AND METHODS FOR CANCER TREATMENT
#95ANTIMONY CHELATES FOR TARGETED AUGER THERAPY AND IMAGING DIAGNOSTICS
#96DLL3 BINDING PEPTIDES AND USES THEREOF
#97NEW PEPTIDE-BASED DIAGNOSTIC AND THERAPEUTIC AGENTS
#98STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF
#99GLUTAMIC ACID -UREA COMPOUND, PREPARATION METHOD AND USE THEREOF, NUCLIDE-TARGETED PROBE, PREPARATION METHOD AND USE THEREOF, AND PHARMACEUTICAL COMPOSITION
#100Radiopharmaceutical and Methods
#101METHOD OF DETECTING PROSTATE CANCER IN A HUMAN SUBJECT USING A Cu 64 PSMA I&T INJECTION
#102UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN NEUROENDOCRINE NEOPLAMS
#103DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF
#104DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF
#105PRODRUGS FOR COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF
#106RADIOPHARMACEUTICAL TREATMENT METHODS AND USE
#107PHARMACOKINETICS AND CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY
#108COMPOUNDS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER
#109COMBINATION THERAPY FOR TREATING LUNG CANCER
#110NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF
#111COMPOUNDS FOR USE IN NON-COVALENT SCAFFOLD AND METHODS RELATED THERETO
#112PSMA Imaging Agents
#113CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY
#114AGENTS, COMPOSITIONS, AND METHODS FOR CANCER DETECTION
#115PSMA Imaging Agents
#116METHOD FOR PREDICTING THE RESPONSE OF A PATIENT DIAGNOSED WITH CANCER TO TREATMENT AND/OR IMAGING WITH A COMPOUND TARGETING CCK2-R, AND COMPOUND FOR USE IN METHODS OF SELECTIVELY TREATING AND/OR IMAGING CANCER
#117RADIOTRACERS AND THERAPEUTICS BINDING TO FIBROBLAST ACTIVATION PROTEIN (FAP)
#118RADIOPHARMACEUTICALS, METHODS FOR THE PRODUCTION THEREOF, AND USES IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES
#119Cleavable radioligands for targeting cell surface receptors and uses thereof
#120DIAGNOSIS AND MONITORING USING EXTRADOMAIN-B FIBRONECTIN TARGETED PROBES
#121STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES
#122Structural Optimization Method to Improve the Theranostic Performance of Peptide Receptor-Targeted Radionuclide Therapy for Cancers
#123PEPTIDE-UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND APPLICATION THEREOF
#124Radiolabeled GRPR-Antagonists for Diagnostic Imaging and Treatment of GRPR-Positive Cancer
#125RADIONUCLIDE LABELED POLYPEPTIDE CONJUGATES AND USES THEREOF
#126Composition containing a somatostatin analogue for radiopharmaceutical use
#127RADIONUCLIDE-LOADED NANOPARTICLES FOR FOCAL TISSUE ABLATION
#128RADIOLABELED MELANOCORTIN 1 RECEPTOR-SPECIFIC ALPHA-MELANOCYTE-STIMULATING HORMONE ANALOGUES FOR IMAGING OR THERAPY
#129NOVEL CXCR4-TARGETING COMPOUNDS
#130POLYPEPTIDE TARGETING INTEGRIN ALPHA 6 AND USE THEREOF
#131FOLATE RECEPTOR-TARGETED CONJUGATES WITH BRUSH BORDER MEMBRANE ENZYME-CLEAVABLE LINKERS AND METHODS OF USE IN IMAGING AND TREATING CANCER
#132PEPTIDE LIGAND TARGETING CARBONIC ANHYDRASE IX, PEPTIDE CONSTRUCT COMPRISING SAME, AND USES THEREOF
#133RADIOPHARMACEUTICAL SOMATOSTATIN RECEPTOR LIGANDS AND PRECURSORS THEREOF
#134RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF
#135SYNTHETIC CYCLIC PEPTIDE MIMETICS
#136CD8A-Binding Fibronectin Type III Domains
#137METHODS FOR DETECTING CCR2 RECEPTORS
#138METHODS AND MATERIALS FOR COMBINING BIOLOGICS WITH MULTIPLE CHELATORS
#139Compounds For Molecular Imaging of Collagen Turnover and Methods Using Same
#140SYNTHESIS OF RESTRAINED COMPLEXING AGENTS
#141CXCR4-TARGETED DIAGNOSTIC AND THERAPEUTIC AGENTS WITH REDUCED SPECIES SELECTIVITY
#142RADIOLABELED COMPOUND AND USE THEREOF
#143BISPIDINE DERIVATIVES AND THE USE THEREOF
#144FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING
#145NANOPARTICLE-MEDIATED ENHANCEMENT OF IMMUNOTHERAPY TO PROMOTE FERROPTOSIS-INDUCED CYTOTOXICITY AND ANTITUMOR IMMUNE RESPONSES
#146RADIOLABELED FIBRONECTIN BASED SCAFFOLDS AND ANTIBODIES AND THERANOSTIC USES THEREOF
#147PET IMAGING TRACERS
#148TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS
#149ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASES
#150IMPROVED PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETING RADIOPHARMACEUTICALS AND USES THEREOF
#151Granzyme-Activatable Membrane-Interacting Peptides and Methods of Use
#152COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF
#153NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF
#154DEVELOPMENT OF CD163 TARGETING AGENT FOR IMAGING AND THERAPY
#155METHODS AND COMPOSITIONS FOR INHIBITING FIBROBLAST ACTIVATION
#156LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME
#157PET TRACER
#158Radiopharmaceuticals at Different Activity Reference Times
#159NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS
#160NEW PEPTIDE-BASED DIAGNOSTIC AND THERAPEUTIC AGENTS
#161[161Tb]-BASED RADIOPEPTIDES
#162COMPOSITIONS, DELIVERY SYSTEMS, AND METHODS USEFUL IN TUMOR THERAPY
#163HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
#164HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#165HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#166CONFORMATIONAL CONSTRAINED SOMATOSTATIN RECEPTOR 3 PEPTIDE LIGANDS AND THEIR CONJUGATES AND USES THEREOF
#167Methods and kits for preparing radionuclide complexes
#168BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE MOIETIES AND USES THEREOF
#169RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE
#170MOLECULAR PROBES AND METHODS OF USE
#171PNA PROBES FOR PRETARGETED IMAGING AND THERAPY
#172HER2 BINDERS
#173NUCLIDE-LABELED INHIBITORY PEPTIDE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#174PEPTIDE RECEPTOR RADIONUCLIDE THERAPY
#175Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders
#176STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF
#177COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF
#178FIBRIN-BINDING COMPOUNDS FOR IMAGING AND TREATMENT
#179COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY
#180NOVEL CXCR4-TARGETING COMPOUNDS
#181IMPROVED CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY
#182COMPOSITIONS, IMAGING, AND THERAPEUTIC METHODS TARGETING FOLATE RECEPTOR 1 (FOLR1)
#183Radiopharmaceuticals, uses thereof, and methods for the production thereof
#184PREDICTING PEPTIDE RECEPTOR RADIOTHERAPY USING A GENE EXPRESSION ASSAY
#185CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF
#186[177LU] LUTETIUM-PSMA I&T COMPOSITION, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
#187PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING
#188RADIOPHARMACEUTICAL COMPOSITIONS OF COPPER FOR TARGETED MOLECULAR IMAGING
#189MACROPINOCYTOSIS SELECTIVE MONOBODY-DRUG CONJUGATES
#190UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR TARGETED RADIOLABELED PEPTIDE CONJUGATES
#191IMAGING METHODS AND RADIOTRACERS FOR USE THEREIN
#192METHOD FOR PRODUCING RADIOACTIVE ZIRCONIUM COMPLEX
#193COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER
#194PROINFLAMMATORY PRODRUGS
#195METHOD FOR PRODUCING RADIOACTIVE ZIRCONIUM COMPLEX
#196OLIGONUCLEOTIDE-BASED THERAPEUTICS AND USES THEREOF
#197BIFUNCTIONAL MACROCYCLIC CHELATE, CONJUGATE, METAL COMPLEX AND USE THEREOF
#198CONJUGATE OR ITS SALT COMPRISING A GASTRIN-RELEASING PEPTIDE RECEPTOR ANTAGONIST AND USES THEREOF
#199RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE
#200METHOD FOR PRODUCING Ac-225 SOLUTION AND METHOD FOR PRODUCING MEDICINE USING Ac-225 SOLUTION
#201BINDING PROTEIN TARGETING HER2, PREPARATION METHOD AND USE THEREOF
#202Theranostic Silicon-Fluoride Heteroaromatic Systems and Methods Thereof
#203PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#204METHODS FOR RADIOLABELLING PSMA BINDING LIGANDS AND THEIR KITS
#205RADIOLABELLED GRPR-ANTAGONIST FOR USE AS THERAGNOSTIC
#206COMPOUNDS FOR USE IN DIAGNOSIS AND/OR MONITORING OF FIBROSIS
#207Stabilized compositions of radionuclides and uses thereof
#208[161 tb]-based radiopeptides
#209PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#210GALLIUM-LABELED GASTRIN ANALOGUE AND USE IN A METHOD OF IMAGING CCKB-RECEPTOR-POSITIVE TUMORS OR CANCERS
#211CHELATOR COMPOSITIONS FOR RADIOMETALS AND METHODS OF USING SAME
#212TRANSDUCED T CELLS EXPRESSING HUMAN SSTR2 AND APPLICATION THEREOF
#213Method and device for direct production of radio-isotope based cancer treatment pharmaceuticals
#214IMAGING COMPOUNDS SELECTIVE FOR NaV1.7
#215Imaging methods using 18F-radiolabeled biologics
#216CONJUGATED AND LABELLED APELIN, PREPARATION AND USES THEREOF
#217SOMATOSTATIN RECEPTOR-BASED CANCER THERAPY
#218REPORTER SYSTEM FOR RADIONUCLIDE IMAGING
#219RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R
#220Composition containing a somatostatin analogue for radiopharmaceutical use
#221COMPOSITIONS AND METHODS OF TARGETING AND IMAGING AGED MICROGLIA WITH AĆ PEPTIDE AMINO ACID RESIDUES FOR V-DOMAIN BINDING OF RAGE
#222CYCLIC PEPTIDES AND THEIR CONJUGATES FOR ADDRESSING ALPHA-V-BETA-6 INTEGRIN IN VIVO
#223VISUALIZATION OF HER2 EXPRESSION IN HUMAN PATIENTS
#224RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF
#225177-LU LABELED ACTIVE SITE INHIBITED FACTOR VII
#226Stabilized compositions of radionuclides and uses thereof
#227CD8A-binding fibronectin type III domains
#228CAR Peptide for Improved Coronavirus Survival
#229NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF
#230SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING AND THERAPY PURPOSES
#231Targeted Radiopharmaceutical for Tumor and Its Use in the Imaging-guided Combination Therapy of Targeted Radiotherapy and Immunotherapy
#232RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN
#233Smart Drug Delivery System and Pharmaceutical Kit for Dual Nuclear Medical Cytotoxic Theranostics
#234STRUCTURAL OPTIMIZATION METHOD TO IMPROVE THE THERANOSTIC PERFORMANCE OF PEPTIDE RECEPTOR-TARGETED RADIONUCLIDE THERAPY FOR CANCERS
#235Immunomodulators
#236RADIOLABELED PEPTIDES FOR NON-INVASIVE DIAGNOSIS AND TREATMENT OF CXCR4 EXPRESSING TUMORS
#237COMPOSITION, KIT AND METHOD FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#238METHODS OF TREATING PSMA-POSITIVE CANCER USING RADIONUCLIDE THERAPY
#239RADIONUCLIDE-LHRH CONJUGATES FOR DIAGNOSIS OF REPRODUCTIVE CANCERS
#240METHODS FOR THE DIAGNOSIS OF LUNG CANCER
#241PSMA-TARGETING IMAGING AGENTS
#242PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#243STABLE, CONCENTRATED RADIOPHARMACEUTICAL COMPOSITION
#244CYCLIC PEPTIDES AS PROTEIN TARGETING AGENTS
#245METHODS FOR RADIOLABELLING GRPR ANTAGONISTS AND THEIR KITS
#246COMPOUNDS HAVING RD TARGETING MOTIFS AND METHODS OF USE THEREOF
#247Method for producing Ac-225 solution and method for producing medicine using Ac-225 solution
#248FORMULATIONS AND KITS FOR THE DIAGNOSTIC EVALUATION OF INFECTIOUS DISEASES AND METHODS THEREOF
#249PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES
#250Methods and kits for preparing radionuclide complexes
#251COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF
#252PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE
#253RADIOPHARMACEUTICAL COMPOUND AND COMPOSITION FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING OF INTERLEUKIN-2 RECEPTOR POSITIVE CELLS, PROCESS FOR THE PREPARATION THEREOF, RELATED KIT AND USES THEREOF
#254COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF
#255COMPOUNDS AND METHODS OF USE
#256A FORMULATION OF A CONJUGATE OF A TUBULYSIN ANALOG TO A CELL-BINDING MOLECULE
#257SURFACE ENHANCED RAMAN SCATTERING NANOPARTICLES AND THEIR USE IN DETECTING AND IMAGING OXIDATIVE STRESS
#258NOVEL RADIOLABELLED CXCR4-TARGETING COMPOUNDS FOR DIAGNOSIS AND THERAPY
#259RK POLYPEPTIDE RADIOPHARMACEUTICAL TARGETING HER2 AND PREPARATION METHOD THEREOF
#260Compositions, delivery systems, and methods useful in tumor therapy
#261POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING
#262RADIOTRACER COMPOSITIONS AND METHODS
#263INDUCING FAVORABLE EFFECTS ON TUMOR MICROENVIRONMENT VIA ADMINISTRATION OF NANOPARTICLE COMPOSITIONS
#264METHODS AND COMPOSITIONS FOR 18F-RADIOLABELING OF BIOLOGICS
#265HER3 peptides for imaging and radiotherapy
#266PEPTIDE PET/SPECT PROBES SPECIFIC TO ONCOPROTEINS IN TUMOR EXTRACELLULAR MATRIX
#267COMPOSITIONS AND METHODS FOR RADIOTHERAPY USING CHELATED RADIOTHERAPEUTIC AGENTS AND NON-TARGET TISSUE BLOCKADE
#268ONE STEP 64Cu-BaBaSar-RGD2 PRODUCTION METHOD
#269PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS WITH IMPROVED TISSUE SPECIFICITY
#270PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#271MILD AND SITE-SELECTIVE 18F-LABELING OF SMALL MOLECULES AND/OR BIOMOLECULES VIA A THIOL-REACTIVE SYNTHON
#272SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS
#273METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS
#274TRANSFERRIN RECEPTOR TARGETING PEPTIDES
#275Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
#276Therapeutic and diagnostic agents for cancer
#277Methods for Synthesis of Radionuclide Complex
#278Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy
#279CXCR4-targeted diagnostic and therapeutic agents with reduced species selectivity
#280PET TRACER FOR IMAGING OF NEUROENDOCRINE TUMORS
#281Radiolabeled GRPR-Antagonists for Diagnostic Imaging and Treatment of GRPR-Positive Cancer
#282LIQUIDLY INJECTABLE, SELF-STABILIZING BIOPOLYMERS FOR THE DELIVERY OF RADIONUCLIDE
#283Pharmaceutical Composition Comprising a Radiolabeled GRPR Antagonist and a Surfactant
#284Enhanced in Vivo Targeting of Site-Specific Drugs
#285CEACAM1 MEDIATED PROTECTIVE IMMUNITY
#286CEACAM1 BASED CANCER THERAPY AND DIAGNOSIS
#287PD-L1 binding polypeptides for imaging
#288RADIOLABELED BOMBESIN-DERIVED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS
#289FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING
#290Pharmacokinetics and cholecystokinin-2 receptor (CCK2R) targeting for diagnosis and therapy
#291RADIOTHERAPEUTIC COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#292PET-IMAGING IMMUNOMODULATORS
#293Compositions and methods for treatment and imaging using nanoparticles
#294Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#295Compounds having RD targeting motifs and methods of use thereof
#296MINIGASTRIN DERIVATES, IN PARTICULAR FOR USE IN CCK2 RECEPTOR POSITIVE TUMOUR DIAGNOSIS AND/OR TREATMENT
#297DETECTING AND TREATING CANCERS USING CELL PENETRANT MTP53-OLIGOMERIZATION-DOMAIN PEPTIDE
#298CD31SHED AS A MOLECULAR TARGET FOR IMAGING OF INFLAMMATION
#299Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancer
#300Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancer